Clinical Trial Update: Effectiveness of Nigella Sativa (Kalonji) Seed in Dyslipidemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the effectiveness of Nigella sativa seed for dyslipidemia; the study, conducted by Aga Khan University, has completed and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypercholesterolemia
• Hypertension
• Metabolic Syndrome

Drugs mentioned

• Nigella sativa seed (Nigella sativa)

Snippet

Sponsor: Aga Khan University | Conditions: Hypercholesterolemia, Hypertension | Phase 1, Phase 2 | Status: COMPLETED